Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2-Reference-Cited by-同舟云学术

Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2

Published:2018-01-07 Issue:2 Volume:5 Page:128-137
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Reetz Kathrin¹²^ORCID,Rodríguez-Labrada Roberto³,Dogan Imis¹²,Mirzazade Shahram¹²,Romanzetti Sandro¹²,Schulz Jörg B.¹²,Cruz-Rivas Edilia M.⁴,Alvarez-Cuesta Jose A.⁴,Aguilera Rodríguez Raul³,Gonzalez Zaldivar Yanetza⁵,Auburger Georg⁶,Velázquez-Pérez Luis³

Affiliation:

1. Department of Neurology; RWTH Aachen University; Pauwelsstr. 30 52074 Aachen Germany

2. JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging; Forschungszentrum Jülich GmbH and RWTH Aachen University; 52074 Aachen Germany

3. Department Clinical Neurophysiology; Centre for the Research and Rehabilitation of Hereditary Ataxias; Calle Libertad 26 Holguín 80100 Cuba

4. Department of Imaging; Clinical-Surgical Hospital “Lucía Iñiguez”. Avenue “Celia; Sanchez 1 Holguín Cuba

5. Department Molecular Genetics; Centre for the Research and Rehabilitation of Hereditary Ataxias; Calle Libertad 26 Holguín 80100 Cuba

6. Experimental Neurology; Goethe University Medical School; 60590 Frankfurt/Main Germany

Funder

Excellence Initiative of the German federal and state governments

Bundesministerium für Bildung und Forschung

Alexander von Humboldt-Stiftung

Cuban Ministry of Public Health

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Reference43 articles.

1. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2;Pulst;Nat Genet,1996

2. Autosomal dominant cerebellar ataxia: clinical analysis of 263 patients from a homogeneous population in Holguin, Cuba;Orozco Diaz;Neurology,1990

3. Molecular epidemiology of spinocerebellar ataxias in Cuba: insights into SCA2 founder effect in Holguin;Velazquez Perez;Neurosci Lett,2009

4. Antisense oligonucleotide therapy for spinocerebellar ataxia type 2;Scoles;Nature,2017

5. Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies;Estrada;Acta Neuropathol,1999

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. On the Cut-Off Value of the Anteroposterior Diameter of the Midbrain Atrophy in Spinocerebellar Ataxia Type 2 Patients;Brain Sciences;2024-01-05

2. Cranial Nerve Thinning Distinguishes RFC1‐Related Disorder from Other Late‐Onset Ataxias;Movement Disorders Clinical Practice;2023-11-29

3. Structural Brain Correlates of Sleep Microstructure in Spinocerebellar Ataxia Type 2 and its role on clinical phenotype;2023-09-07

4. Autosomal dominant cerebellar ataxias: new genes and progress towards treatments;The Lancet Neurology;2023-08

5. Analysis and hierarchical clustering of infratentorial morphological MRI identifies SCAs phenogroups;Journal of Neurology;2023-06-08